PDB62 - COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN IN JAPAN BASED ON RESULTS FROM THE SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE EMPA-REG OUTCOME TRIAL
Abstract
Authors
K. Kaku M. Haneda H. Sakamaki A. Yasui T. Murata A.V. Ustyugova R. Chin T. Hirase T. Shibahara N. Hayashi A. Kansal S. Kaspers T. Okamura